Genetics and epigenetics

Research reveals a potential predictor of bronchopulmonary dysplasia risk in preterm infants

A blood test that can predict treatment response and reveal evolving resistance in prostate cancer

Epigenetics may predict the risk of developing anal cancer

New collaborative guidelines for molecular biomarker testing in colorectal cancer

Two experts explain why they believe ctDNA analysis is the future of cancer pathology

George Calin, Professor, Department of Experimental Therapeutics, and Co-Director, The Center for RNA Interference and Non-coding RNAs, MD Anderson Cancer Center, USA

To win the war on cancer, we need to put proteomics on an equal footing with genomics

New biomarkers could predict cognitive decline in Parkinson's disease patients

Ultrasensitive mutation analysis could boost the potential of liquid biopsy

A genome-wide study shows that anorexia isn't purely psychiatric: metabolic factors also play a role